crotamiton,
Eurax,
crotamiton,
483-63-6,
N-Ethyl-o-crotonotoluidide,
Crotamitone,
Eurax,
Crotalgin,
Veteusan,
Eurasil,
Euraxil,
trans-Crotamiton,
Crotamitonum,
Crotamitex,
Crotan,
Crotonyl-N-ethyl-o-toluidine,
124236-29-9,
2-Butenamide, N-ethyl-N-(2-methylphenyl)-,
Caswell No. 431B,
Crotamitonum [INN-Latin],
UNII-2EEH27851Y,
o-CROTONOTOLUIDIDE, N-ETHYL-,
EINECS 207-596-3,
MFCD00026989,
EPA Pesticide Chemical Code 055701,
BRN 3275497,
N-Ethyl-N-(2-methylphenyl)-2-butenamide,
AI3-17732,
DNTGGZPQPQTDQF-XBXARRHUSA-N,
2EEH27851Y,
(E)-N-Ethyl-N-(o-tolyl)but-2-enamide,
N-ethyl-N-(2-methylphenyl)but-2-enamide,
(E)-N-ethyl-N-(2-methylphenyl)but-2-enamide,
Q-200893,
Bestloid,
SMR000059145,
Crotamiton, (E)-,
(2E)-N-ethyl-N-(2-methylphenyl)but-2-enamide,
SR-01000759366,
CHEBI:31439,
Crotamiton [INN:BAN:JAN],
Crotamiton [USP:INN:BAN:JAN],
AK307309,
Eurax (TN),
AC1LEL5N,
AC1Q2YLR,
Prestwick2_000951,
Prestwick3_000951,
N-Ethyl-o-crotonotoluidine,
G 7857,
AC1Q5IA6,
N-Ethyl- o-crotonotoluidide,
SCHEMBL32934,
BSPBio_000942,
BSPBio_002722,
Crotamiton (JAN/USP/INN),
3-12-00-01856 (Beilstein Handbook Reference),
MLS000759489,
MLS001424003,
MLS002222307,
MLS002695895,
N-Ethyl-ortho-crotonotoluidide,
SPECTRUM1505271,
2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (E)-,
2-Butenamide, N-ethyl-N-(2-methylphenyl)-, (2E)-,
BPBio1_001038,
component of Eurax (Salt/Mix),
N-Crotonyl-N-ethyl-o-toluidine,
CHEMBL1200709,
ZINC56427,
N-Ethyl-o-crotonotoluidide, 97%,
HMS1570P04,
HMS1922P21,
HMS2051E10,
HMS2090A10,
HMS2093O12,
HMS2097P04,
HMS2234E16,
HMS3714P04,
Pharmakon1600-01505271,
BCP13315,
HY-B1177,
NSC78382,
CCG-39402,
NSC-78382,
NSC758951,
SBB057407,
(E)-N-ethyl-N-o-tolylbut-2-enamide,
AKOS015892746,
CS-4730,
N-Ethyl-N-(2-methylphenyl)-butenamide,
NC00107,
NSC-758951,
NCGC00094571-01,
NCGC00094571-02,
NCGC00094571-03,
NCGC00094571-04,
NCGC00094571-05,
AS-11641,
BBV-42867418,
CC-26001,
CPD000059145,
LS-55636,
SAM001246702,
SC-15884,
SC-89488,
trans-N-Ethyl-N-(o-tolyl)-2-butenamide,
ZB001632,
SBI-0206763.P001,
2-Butenamide,N-ethyl-N-(2-methylphenyl)-,
AB2000238,
AB00513973,
E0814,
N-Ethyl-N-(2-methylphenyl)-2-butenamide #,
ST50409628,
(E)-N-ethyl-N-(2-methylphenyl)-2-butenamide,
A10243,
D01381,
AB00513973-09,
AB00513973_10,
483C636,
A827519,
I04-0177,
SR-01000759366-4,
SR-01000759366-6,
BRD-K13240564-001-01-8,
BRD-K57179821-001-05-5,
BRD-K57179821-001-08-9,
I01-20166,
Crotamiton, British Pharmacopoeia (BP) Reference Standard,
Crotamiton, European Pharmacopoeia (EP) Reference Standard,
UNII-D6S4O4XD0H component DNTGGZPQPQTDQF-XBXARRHUSA-N,
Crotamiton, United States Pharmacopeia (USP) Reference Standard,
InChI=1/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4,
null,
Creatine monohydrate,
UNII-D6S4O4XD0H,
C13H17NO,
N-Ethyl-O-crotontoluidide,
D0T3NY,
D6S4O4XD0H,
Crotamiton [BAN:INN:JAN],
ACN-S001991,
C13-H17-N-O,
AR-1I2742,
CID688020,
N-ethyl-o-crotonotoluidine/Crotamiton,
CS-O-01247,
2-Butenamida, N-etil-N-(2-metilfenil)-,
C005553,
34824-60-7,